Synthetic Biology’s Second World
By Andy Balmer,
PLOS Synbio Community
| 05. 16. 2016
Secrecy has long been a part of scientific and innovation practices. Being an ethnographer of laboratories, one occasionally comes up against a barrier of entry to a secret lab or space within a building, protected by intellectual property agreements, military or government contracts. Of course, military science is often conducted in secret, on nuclear, biological or chemical weapons, amongst other things. In his excellent book on ‘Secrecy and Science’, Brian Balmer describes how the Manhattan Project epitomised the way in which scientific secrecy operates at various levels of social organisation:
It was, in fact, an almost unprecedented organisation of not only scientists, but also industry and military. Moreover, a significant feature that accounts for the success of the Manhattan Project is the preoccupation with secrecy at the various sites involved in creating the atomic bomb. Compartmentalisation, telling people information on a strict need-to-know basis, meant only a few people had a complete overview of the project. […] In this manner, efficiency, security, bureaucracy and secrecy all came together at once. (Balmer, 2013: 8)
It is often the most controversial, risky...
Related Articles
By Grace Won, KQED [with CGS' Katie Hasson] | 12.02.2025
In the U.S., it’s illegal to edit genes in human embryos with the intention of creating a genetically engineered baby. But according to the Wall Street Journal, Bay Area startups are focused on just that. It wouldn’t be the first...
Several recent Biopolitical Times posts (1, 2, 3, 4) have called attention to the alarmingly rapid commercialization of “designer baby” technologies: polygenic embryo screening (especially its use to purportedly screen for traits like intelligence), in vitro gametogenesis (lab-made eggs and sperm), and heritable genome editing (also termed embryo editing or reproductive gene editing). Those three, together with artificial wombs, have been dubbed the “Gattaca stack” by Brian Armstrong, CEO of the cryptocurrency company...
Alice Wong, founder of the Disability Visibility Project, MacArthur Genius, liberationist, storyteller, writer, and friend of CGS, died on November 14. Alice shone a bright light on pervasive ableism in our society. She articulated how people with disabilities are limited not by an inability to do things but by systemic segregation and discrimination, the de-prioritization of accessibility, and the devaluation of their lives.
We at CGS learned so much from Alice about disability justice, which goes beyond rights...
By Adam Feuerstein, Stat | 11.20.2025
The Food and Drug Administration was more than likely correct to reject Biohaven Pharmaceuticals’ treatment for spinocerebellar ataxia, a rare and debilitating neurodegenerative disease. At the very least, the decision announced Tuesday night was not a surprise to anyone paying attention. Approval...